To pop or not to pop: p53 as a critical modulator of tumour responsiveness to therapy in vivo?

doi:10.1177/096032719501400213

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

To pop or not to pop: p53 as a critical modulator of tumour responsiveness to therapy in vivo?

Human & experimental toxicology - 1 Feb 1995

Workman P

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apoptosis
Share to Cell Cycle
Share to DNA Damage
Share to DNA Repair

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Expression Regulation, Neoplastic

Share to Genes, p53

Share to Genetic Therapy

Share to Tumor Suppressor Protein p53

Source

Open in PubMed

Identifiers

PMID: 7779451
DOI: 10.1177/096032719501400213

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

To pop or not to pop: p53 as a critical modulator of tumour responsiveness to therapy in vivo?PMID 7779451Read ↗

Tumour biology: Policing of oncogene activity by p53.Semantic proximity Read ↗

Tumor suppression: putting p53 in context.Semantic proximity Read ↗

p53: regular or super?Semantic proximity Read ↗

p53: emergency brake and target for cancer therapy.Semantic proximity Read ↗

Shifting the paradigms for tumor suppression: lessons from the p53 field.Semantic proximity Read ↗

p53: balancing tumour suppression and implications for the clinic.Semantic proximity Read ↗

The guardian of the genome meets immunotherapy: p53-based strategies.Semantic proximity Read ↗

Cancer therapy meets p53.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.